The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.
Chiesi Global Rare Diseases is committing up to $115 million to begin a collaboration on Arbor Biotechnologies’ in vivo gene-editing therapy for primary hyperoxaluria type 1, an inherited liver disorder. It’s the rare disease company’s first foray into genetic medicines. The post Chiesi’s Rare Disease Strategy Expands to Genetic Meds via Alliance With CRISPR Startup…
Ask any healthcare revenue cycle manager how they feel about using artificial intelligence (AI), and the response is likely to be “hopeful, but wary.” The potential is clear — fewer denials, faster reimbursements and more efficient workflows. However, with adoption slowing, it seems many have lingering concerns about implementation. According to Experian Health’s State of…
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 2023. The post Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023 appeared first on MedCity News.
[Sponsored] Philips ventilators are known for their reliability, patient comfort and advanced monitoring features, but access depends on choosing the right rental partner. The post 6 Places You Can Rent a Philips Ventilator appeared first on MedCity News.
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Women’s Health? appeared first on MedCity News.
The Trump administration has cancelled $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses. In addition, since President Donald Trump took office, at least half of the security council’s staff have been laid off or left. This is dangerous say former health security officials. The post In Axing mRNA Contract, Trump…
The FDA will provide faster regulatory review of generic drugs that are tested in and manufactured in the U.S. using domestically sourced active pharmaceutical ingredients. This FDA pilot program is part of a broader Trump administration strategy to reshore pharmaceutical production. The post FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic…
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication. The post Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? appeared first on MedCity News.
The promise of current and future technologies is encouraging – and it further underscores the importance of building the right support systems to help patients navigate the system and access the appropriate care at the right time and place. The post Better Navigation is Key to Improving Behavioral Health Access and Outcomes appeared first on…